EuroAPI Header EuroAPI Header

X

Find the latest Drugs in Development and Pipeline Prospector News of Vils Pharma Coating.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Vils Pharma Coating
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
Vils Pharma Coating Inc., 135 Glendale Ave, Edison, NJ 08817
Telephone
Telephone
+1 (732) 777-9697
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

left grey arrow
right gray arrow

Details:

Under the terms of the agreement, Novo Nordisk will receive an exclusive, worldwide licence to use Aspect’s bioprinting technology to develop bioprinted tissue therapeutics including up to four products for the treatment of diabetes and obesity.


Lead Product(s): Bioprinted-based Tissue Therapy

Therapeutic Area: Endocrinology Product Name: Undisclosed

Highest Development Status: UndisclosedProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Novo Nordisk

Deal Size: $2,675.0 million Upfront Cash: $75.0 million

Deal Type: Collaboration April 12, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY